Nymox Pharmaceutical Release: Two New Published Studies Emphasize the Need for Testing Tobacco Use and Second-Hand Smoke Exposure

HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--Nymox Pharmaceutical Corporation (NASDAQ:NYMX) reported today that newly published studies show the need for independent confirmation of smoking status. The Company’s NicAlert™ and TobacAlert™ products allow for quick and convenient on-site monitoring of tobacco and second-hand smoke exposure.